Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 192,839 | 1,347,799 | 922,551 | 524,353 | 199,752 |
| Depreciation Amortization | 541,827 | 1,697,563 | 1,317,181 | 873,648 | 415,461 |
| Income taxes - deferred | -12,033 | -30,789 | -35,717 | -60,289 | -32,118 |
| Accounts receivable | -447,301 | -78,136 | -196,373 | -124,433 | -308,824 |
| Accounts payable and accrued liabilities | 22,570 | 30,790 | 36,124 | -6,659 | 53,014 |
| Other Working Capital | -419,047 | 156,403 | -17,143 | -117,108 | -405,623 |
| Other Operating Activity | 386,693 | -90,348 | -63,674 | -24,974 | 249,872 |
| Operating Cash Flow | $265,549 | $3,033,282 | $1,962,949 | $1,064,538 | $171,535 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -218,853 | -1,016,760 | -561,908 | -327,845 | -149,908 |
| Net Acquisitions | -3,666 | 203,842 | 169,385 | 5,118 | 13,361 |
| Purchase Of Investment | -82 | -99,021 | -29,742 | -12,945 | -12,189 |
| Sale Of Investment | 24,243 | 94,469 | 66,568 | 51,537 | 34,704 |
| Investing Cash Flow | $-198,358 | $-817,471 | $-355,696 | $-284,135 | $-114,032 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 148,287 | 177,016 | 186,260 | 107,004 | 97,041 |
| Debt Issued | 54,110 | 1,835,756 | 1,311,264 | 1,264,843 | 14,850 |
| Debt Repayment | -11,518 | -949,907 | -970,473 | -359,751 | -15,158 |
| Common Stock Repurchased | -406,516 | -662,192 | -176,643 | N/A | N/A |
| Dividend Paid | -91,579 | -1,127,424 | -1,084,528 | -613,300 | -67,855 |
| Other Financing Activity | -203,179 | -860,838 | -662,502 | -466,415 | -175,092 |
| Financing Cash Flow | $-510,395 | $-1,587,588 | $-1,396,623 | $-67,618 | $-146,213 |
| Exchange Rate Effect | 21,898 | -160,067 | -127,762 | -105,670 | -23,634 |
| Beginning Cash Position | 1,871,602 | 1,341,080 | 1,385,530 | 1,345,584 | 1,248,743 |
| End Cash Position | 1,450,295 | 1,809,236 | 1,468,398 | 1,952,699 | 1,136,399 |
| Net Cash Flow | $-421,307 | $468,156 | $82,868 | $607,115 | $-112,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | 265,549 | 3,033,282 | 1,962,949 | 1,064,538 | 171,535 |
| Capital Expenditure | -222,453 | -1,035,648 | -575,516 | -340,722 | -153,558 |
| Free Cash Flow | 43,095 | 1,997,634 | 1,387,433 | 723,816 | 17,977 |